Cash flow MicroPort Scientific Corporation
Equities
853
KYG608371046
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.600 HKD | +0.66% | -1.29% | -45.37% |
08-30 | MicroPort Scientific Corporation Reports Earnings Results for the Half Year Ended June 30, 2024 | CI |
08-23 | MicroPort CardioFlow Medtech to Buy Industrial Site from MicroPort Medical | MT |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Net Income | 46.28M | -191M | -276M | -437M | -478M | |||||
Depreciation & Amortization - CF | 51.41M | 56.75M | 77.75M | 122M | 132M | |||||
Amortization of Goodwill and Intangible Assets - (CF) | 5.74M | 8.16M | 7.6M | 9.25M | 10.88M | |||||
Depreciation & Amortization, Total | 57.14M | 64.91M | 85.35M | 131M | 143M | |||||
Amortization of Deferred Charges, Total - (CF) | 4.04M | 5.67M | 8.28M | 10.18M | 8.58M | |||||
(Gain) Loss From Sale Of Asset | -63.7M | 570K | -7.81M | -6.65M | 3.89M | |||||
(Gain) Loss on Sale of Investments - (CF) | 2M | 12.18M | -34.92M | -38.52M | -2.31M | |||||
Asset Writedown & Restructuring Costs | 450K | 114K | 251K | 23.56M | 156M | |||||
(Income) Loss On Equity Investments - (CF) | 5.66M | 6.73M | 13.26M | 42.54M | 32.47M | |||||
Stock-Based Compensation (CF) | 18.53M | 55.66M | 91.34M | 72.8M | 39.66M | |||||
Other Operating Activities, Total | 8.6M | -20.62M | -69.38M | -72.55M | -101M | |||||
Change In Accounts Receivable | -44.45M | 35.82M | -86.16M | 23.65M | -27.97M | |||||
Change In Inventories | -24.07M | -47.87M | -51.78M | -79.33M | -62.47M | |||||
Change In Accounts Payable | 21.69M | 2.64M | 117M | -18.36M | 52.74M | |||||
Change in Unearned Revenues | -5.72M | 52.22M | -46.88M | 4.72M | 3.34M | |||||
Cash from Operations | 26.45M | -23.2M | -258M | -343M | -232M | |||||
Capital Expenditure | -97.04M | -104M | -222M | -235M | -167M | |||||
Sale of Property, Plant, and Equipment | 3.47M | 2.09M | 4.9M | 428K | 1.09M | |||||
Cash Acquisitions | - | - | -238M | - | -17.9M | |||||
Divestitures | 31.03M | - | -2.25M | - | - | |||||
Sale (Purchase) of Intangible assets | -18.05M | -16.87M | -26.17M | -21.88M | -32.4M | |||||
Investment in Marketable and Equity Securities, Total | -10.96M | -36.85M | -203M | -120M | -297M | |||||
Other Investing Activities, Total | 11.6M | 7M | 30.37M | -35.46M | 136M | |||||
Cash from Investing | -79.96M | -148M | -656M | -413M | -377M | |||||
Short Term Debt Issued, Total | 2.04M | - | - | - | - | |||||
Long-Term Debt Issued, Total | 162M | 199M | 1.02B | 464M | 562M | |||||
Total Debt Issued | 164M | 199M | 1.02B | 464M | 562M | |||||
Short Term Debt Repaid, Total | - | -633K | - | - | - | |||||
Long-Term Debt Repaid, Total | -85.1M | -294M | -144M | -231M | -345M | |||||
Total Debt Repaid | -85.1M | -295M | -144M | -231M | -345M | |||||
Issuance of Common Stock | 1.85M | 211M | 8.48M | 5.38M | 24.93M | |||||
Repurchase of Common Stock | -17.63M | -3.5M | -45.26M | -23.2M | -1.19M | |||||
Common Dividends Paid | -3.43M | -6.66M | -6.42M | - | - | |||||
Common & Preferred Stock Dividends Paid | -3.43M | -6.66M | -6.42M | - | - | |||||
Other Financing Activities, Total | 148M | 742M | 827M | 57.68M | 194M | |||||
Cash from Financing | 207M | 847M | 1.66B | 273M | 435M | |||||
Foreign Exchange Rate Adjustments | -3.83M | 46.44M | 5.34M | -68.35M | -9.67M | |||||
Net Change in Cash | 150M | 722M | 752M | -551M | -183M | |||||
Supplemental Items | ||||||||||
Cash Interest Paid | 19.22M | 13.48M | 14.38M | 23.66M | 42.36M | |||||
Cash Income Tax Paid (Refund) | 24.2M | 13.97M | 57.68M | 3.28M | 25.62M | |||||
Levered Free Cash Flow | -7.91M | 55.96M | -502M | -412M | -539M | |||||
Unlevered Free Cash Flow | 6.28M | 79.33M | -476M | -365M | -481M | |||||
Change In Net Working Capital | -26.67M | -188M | 220M | 9.82M | 233M | |||||
Net Debt Issued / Repaid | 78.91M | -95.86M | 877M | 233M | 217M |